MarketCap
Facebook
X
Telegram
Harrow Health EV | HROW
EV Jährlich Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.21 B | 2.15 B | 515 M | 513 M | 252 M | 260 M | 190 M | 149 M | 55.5 M | 42 M | 69.9 M | 61.2 M | 56.1 M | 27.7 M | 3.15 M | 638 M | -1.59 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.21 B | -1.59 M | 423 M |
EV anderer Aktien in der Arzneimittelhersteller
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Evoke Pharma
EVOK
|
-3.12 M | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
560 M | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-974 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
6.79 M | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
-1.35 M | $ 3.26 | 0.62 % | $ 1.25 B | Canada |
 |
China Pharma Holdings
CPHI
|
10.7 M | $ 0.82 | 0.1 % | $ 3.52 M |  China |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | - | - | $ 2.06 B |  France |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
126 M | $ 6.79 | 0.59 % | $ 101 M | USA |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-11 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Jupiter Wellness
JUPW
|
3.7 M | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
467 M | $ 9.3 | 2.76 % | $ 600 M | USA |
 |
Lannett Company
LCI
|
671 M | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-80.1 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
238 M | - | - | $ 150 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-22.6 M | - | - | $ 55.5 M | USA |
 |
Radius Health
RDUS
|
715 M | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
396 B | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
84.7 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
75 M | - | -27.8 % | $ 2.56 M | USA |
 |
OrganiGram Holdings
OGI
|
146 M | $ 1.16 | 0.42 % | $ 111 M | Canada |
 |
Zomedica Corp.
ZOM
|
2.62 M | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
555 M | - | - | $ 3.25 M | USA |
 |
Bausch Health Companies
BHC
|
26.7 B | $ 6.56 | 5.56 % | $ 2.43 B | Canada |
 |
Emergent BioSolutions
EBS
|
1.04 B | $ 6.21 | 0.08 % | $ 332 M | USA |
 |
Rockwell Medical
RMTI
|
43.3 M | $ 7.99 | 1.31 % | $ 287 M | USA |
 |
Organogenesis Holdings
ORGO
|
408 M | $ 1.71 | 4.27 % | $ 217 M | USA |
 |
Solid Biosciences
SLDB
|
616 M | $ 10.25 | 1.31 % | $ 897 M | USA |
 |
Sundial Growers
SNDL
|
331 M | $ 1.44 | 1.77 % | $ 372 M | Canada |
 |
Perrigo Company plc
PRGO
|
7.03 B | $ 14.92 | 4.56 % | $ 2.07 B | USA |
 |
Tilray
TLRY
|
4.01 B | $ 4.5 | 0.22 % | $ 4.01 B | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
10.3 M | $ 1.33 | 0.38 % | $ 2.24 M | USA |
 |
Relmada Therapeutics
RLMD
|
251 M | $ 4.43 | 1.37 % | $ 175 M | USA |
 |
SCYNEXIS
SCYX
|
26.3 M | $ 5.3 | 0.47 % | $ 265 M | USA |
 |
Veru
VERU
|
80.7 M | $ 2.64 | 0.94 % | $ 38.7 M | USA |
 |
Viatris
VTRS
|
21.2 B | $ 16.88 | 0.03 % | $ 19.4 B | USA |
 |
TherapeuticsMD
TXMD
|
26.3 M | $ 2.21 | 0.22 % | $ 25.6 M | USA |
 |
cbdMD
YCBD
|
4.51 M | $ 0.5 | 4.68 % | $ 2.01 M | USA |
 |
Canopy Growth Corporation
CGC
|
349 M | $ 0.97 | 0.17 % | $ 289 M | Canada |
 |
ProPhase Labs
PRPH
|
56.3 M | - | - | $ 5.07 M | USA |
 |
Aurora Cannabis
ACB
|
330 M | $ 3.95 | 1.54 % | $ 217 M | Canada |